ElectroPhySiological Characterization Of the Arrhythmia Substrate for Sudden Cardiac Death PrEdiction

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 210 participants.

Also called NCT07020702

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 210 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07020702
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
France (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07020702. Non-randomized; no masking; primary purpose prevention. Start 2023-06-12 (actual); primary completion 2030-09-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ElectroPhySiological Characterization Of the Arrhythmia Substrate for Sudden Cardiac Death PrEdiction
Acronym
EP-SCOPE
Condition
Ventricular Arrhythmia
Condition
Cardiomyopathies
Condition
Left Ventricular Ejection Fraction Less Then or Equal to 50percent
Intervention (Device)
Implantation of an ICD
Lead sponsor
University Hospital, Bordeaux (class: other)

Record details

Record id
cardio:ct-nct07020702
Content hash
8a06b18ab344b3d07b25fe882d2949870725f1682d5644ca961c78f081321e75